Table 3 Univariate survival analysis of the patients with stage III colorectal cancer
Characteristics | N | 1 year survival (%) | 5 year survival (%) | 10 year survival (%) | P value |
|---|---|---|---|---|---|
Age | |||||
<50 | 56 | 95.6 ± 2.9 | 79.1 ± 6.7 | 70.3 ± 10.2 | |
50 to 60 | 33 | 100 | 64.3 ± 13.2 | 42.9 ± 19.5 | |
61 to 70 | 35 | 90 ± 5.5 | 70.1 ± 11.2 | 19.5 ± 16.6 | |
> 71 | 39 | 80.5 ± 7.4 | 68.5 ± 10.1 | 68.5 ± 10.1 | 0.25 |
LNR | |||||
0 to 0.4 | 116 | 94.1 ± 2.3 | 77.3 ± 5.8 | 60.6 ± 9.9 | |
> 0.4 | 41 | 86.2 ± 6.6 | 40.6 ± 13.4 | 0 | <0.01 |
+LN | |||||
1 to 3 | 95 | 94.3 ± 2.5 | 76.3 ± 6 | 58.4 ± 10.5 | |
> 4 | 63 | 89.2 ± 4.7 | 51.1 ± 13.1 | 19.2 ± 15.5 | <0.05 |
Stage III | |||||
IIIA | 13 | 91 ± 8.7 | 75.8 ± 15.6 | 75.8 ± 15.6 | |
IIIB | 108 | 94 ± 2.4 | 77.1 ± 5.7 | 56 ± 10.4 | |
IIIC | 42 | 84.7 ± 7.2 | 22 ± 17.4 | 0 | 0.01 |
Adjuvant chemotherapy | |||||
No | 42 | 78.1 ± 6.9 | 65.6 ± 10.4 | 43.5 ± 14.4 | |
Yes | 81 | 97.3 ± 1.9 | 68.2 ± 7.3 | 42.2 ± 18.1 | 0.16 |
Gender | |||||
Female | 85 | 94.4 ± 2.8 | 66.1 ± 7.9 | 49.6 ± 11.7 | |
Male | 78 | 89.7 ± 3.7 | 73.3 ± 7.8 | 44 ± 15.2 | 0.10 |
LN resected | |||||
0 – 11 | 37 | 90.9 ± 5 | 59.9 ± 10.4 | 59.9 ± 10.4 | |
≥ 12 | 123 | 92.1 ± 2.7 | 71.7 ± 6.8 | 40.9 ± 12.3 | 0.401 |
Grade | |||||
Well-differentiated | 6 | 83.3 ± 15.2 | 41.7 ± 30.4 | ––– | |
Moderately differentiated | 92 | 93.6 ± 2.8 | 68.9 ± 7.5 | 51.9 ± 10.5 | |
Poorly differentiated | 52 | 90.9 ± 4.4 | 67 ± 9.9 | 25.1 ± 19.6 | 0.61 |
Recurrence | |||||
No | 67 | 83.9 ± 4.7 | 64.9 ± 6.9 | 50.5 ± 10.6 | |
Yes | 30 | 96.6 ± 3.4 | 64.4 ± 13.1 | 32.2 ± 17.4 | 0.41 |